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Abstract
Impaired mitochondrial oxidative phosphorylation (OXPHOS) has been proposed as an etiological mechanism underlying
insulin resistance. However, the initiating organ of OXPHOS dysfunction during the development of systemic insulin
resistance has yet to be identified. To determine whether adipose OXPHOS deficiency plays an etiological role in systemic
insulin resistance, the metabolic phenotype of mice with OXPHOS–deficient adipose tissue was examined. Crif1 is a protein
required for the intramitochondrial production of mtDNA–encoded OXPHOS subunits; therefore, Crif1 haploinsufficient
deficiency in mice results in a mild, but specific, failure of OXPHOS capacity in vivo. Although adipose-specific Crif1-
haploinsufficient mice showed normal growth and development, they became insulin-resistant. Crif1-silenced adipocytes
showed higher expression of chemokines, the expression of which is dependent upon stress kinases and antioxidant.
Accordingly, examination of adipose tissue from Crif1-haploinsufficient mice revealed increased secretion of MCP1 and
TNFa, as well as marked infiltration by macrophages. These findings indicate that the OXPHOS status of adipose tissue
determines its metabolic and inflammatory responses, and may cause systemic inflammation and insulin resistance.
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Introduction
White adipose tissue (WAT) determines whole-body energy
metabolism by controlling lipid storage and by releasing
adipokines, which may directly or indirectly affect the physiolog-
ical functions of almost all cell types (for a review, see [1,2]). These
adipocyte functions are perturbed by genetic and environmental
factors, which lead to adipocyte dysfunction characterized by
hypertrophy, hypoxia and inflammatory process within adipose
tissue [3]. Adipocyte dysfunction is further characterized by
impaired insulin sensitivity, which is associated with changes in
cellular composition or organelle dysfunction, particularly of the
endoplasmic reticulum (ER) and mitochondria. An emerging
concept to explain insulin resistance in obese individuals is
maladaptive responses within the ER, which are prominent in
adipose tissue (for a review, see [4–6]).
Besides the ER, the mitochondria in white adipocytes are linked
with adipocyte differentiation and with the function of mature
adipocytes. Recent studies show that drastic increases in
mitochondrial biogenesis and reactive oxygen species (ROS)
production via the OXPHOS complex play a crucial role in
adipocyte differentiation. In addition, the mitochondria in
differentiating adipocytes support high energy-consuming lipo-
genic processes to maintain mature adipocyte function [5,7].
Therefore, it is suggested that the contribution of adipocyte
mitochondria to whole-body energy metabolism or adipocyte
plasticity may depend on the mitochondrial OXPHOS capacity of
the adipose tissue [6]. Consistent with this, decreased mitochon-
drial capacity in adipocytes may also alter their insulin sensitivity
and/or function due to the high energy requirements of fatty acid
storage, adipokine secretion, insulin signaling, and glucose uptake
[8,9].
It is interesting that a marked decrease in the level of transcripts
for nuclear-encoded mitochondrial genes in cells derived from the
epididymal fat pads of ob/ob mice accompanies the onset of obesity
[10]. In db/db and diet-induced obese mice, the expression of
OXPHOS genes was markedly reduced compared with that in db/
+ mice and control mice fed a standard-fat diet, respectively [11].
In humans, the mtDNA copy number is enriched in adipocytes in
adipose tissue, but it decreases slightly with age and increasing
BMI, and shows a strong positive correlation with basal and
insulin-stimulated lipogenesis in fat cells [12]. More interestingly,
suppression of OXPHOS genes is prominent in the visceral
adipose tissue of humans with type 2 diabetes independent of
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obesity [13]. Agonists of peroxisome proliferator-activated recep-
tor-gamma (PPARc) increase the number of mitochondria and
induce mitochondrial remodeling in adipocytes [10,11,14], and
significantly increase the mitochondrial copy number and
expression of factors involved in mitochondrial biogenesis,
including PPARc coactivator-1alpha (PGC1a) and mitochondrial
transcription factor A (TFAM), which are required for mitochon-
drial transcription of OXPHOS genes in humans [15]. These
observations in rodent models and human subjects suggest that the
OXPHOS capacity of adipose tissue may affect the changes in
adipocyte plasticity, which controls insulin sensitivity and may
determine the therapeutic responsiveness to antidiabetic agents
such as thiazolidinediones and CB1 receptor blockers that affect
the mitochondrial content of adipocytes [10,16].
Here, we demonstrate that primary OXPHOS dysfunction in
adipose tissue causes insulin resistance and a diabetic phenotype in
mice with a Crif1 loss-of-function mutation. Crif1 is a mitochon-
drial protein that associates with large mitoribosomal subunits,
which are located close to the polypeptide exit tunnel, and the
elimination of Crif1 led to both aberrant synthesis and defective
insertion of mtDNA-encoded nascent OXPHOS polypeptides into
the inner membrane [17]. Targeted elimination of the Crif1 gene
resulted in a phenotype characterized by organ-specific failure of
OXPHOS function; therefore, we attempted to identify the
adipose tissue phenotypes of adipose-specific Crif1-knockout mice
using Fabp4-Cre and Adiponectin-Cre mice models. Reduced
OXPHOS capacity in the WAT of Crif1-deficient mice triggered
spontaneous adipose inflammation, which was characterized by
macrophage infiltration and systemic insulin resistance. Therefore,
the OXPHOS reserve may be the critical determinant controlling
the metabolic and inflammatory responses of adipose tissue, which
are closely related to systemic changes in insulin sensitivity.
Results
Homozygotic loss of Crif1 causes marked impairment of
WAT development
Crif1 is a mitochondrial protein that specifically interacts with
the protein components of the large subunit of the mitochondrial
ribosome [17]. It specifically regulates the translation and insertion
of the 13 polypeptide subunits that comprise mitochondrial
OXPHOS complexes I, III, IV and V. Homozygous Crif1-null
mouse embryonic fibroblasts (MEFs) showed a profound failure in
translation and expression of these subunits, along with markedly
low levels of basal and stimulated (CCCP-treated) mitochondrial
oxygen consumption [17]. Disruption of the mouse Crif1 gene
consistently resulted in a profound OXPHOS deficiency charac-
terized by the loss of OXPHOS complex subunits and respiratory
complexes in vivo.
Crif1 mRNA is ubiquitously expressed, and it is highly expressed
in brain, heart, liver kidney and skeletal muscle (Figure S1A). Two
types of adipose tissues, brown (BAT) and white (WAT), contained
substantial amounts of Crif1 mRNA (Figure S1A). Crif1 mRNA
levels were decreased in the WAT, BAT and liver of db/db and ob/
ob mice compared to db/+ and ob/+ mice, respectively (Figure
S1B). Interestingly, Crif1 mRNA expression in WAT of C57BL/6
mice was downregulated when they were fed a high fat diet (HFD)
for 8 weeks (Figure S1C). These findings indicate that Crif1
expression correlates with the nutritional status in adipose tissue.
To identify the roles of Crif1 and mitochondrial OXPHOS in
adipose tissue, we tried to induce primary OXPHOS deficiency in
adipose tissue in vivo using conditional Crif1 knockout mice. We
crossed conditional Crif1 mice (Crif1flox/flox) [18] with mice
expressing a Cre recombinase gene under the control of the fatty
acid binding protein-4 (Fabp4) promoter (Fabp4-Cre) and the
adiponectin promoter (Adipoq-Cre). The resulting pups were born
healthy and viable, and showed a normal Mendelian ratio.
However, these homozygous Crif1f/f,Fabp4 mice showed delayed
weight gain and poor development of adipose tissue (Figure 1A–
1C). Unlike the control (Crif1+/+,Fabp4) and Crif1 heterozygous
(Crif1f/+Fabp4) mice, Crif1f/f,Fabp4 mice showed uniform lethality
within 24 days of birth (median survival = 19.4 days) (Figure 1D).
The perirenal, subcutaneous and epididymal fat pads of Crif1f/
f,Fabp4 mice comprised small adipocytes with dystrophic changes
(Figure 1E). To verify any mitochondrial abnormalities, the
adipose tissues of Crif1f/f,Fabp4 mice were examined by transmission
electron microscopy (TEM). The adipocytes of these mice
contained mitochondria with ultrastructural abnormalities, such
as swollen and distorted cristae, but mitochondrial number was
unaffected (Figure 1F and 1G). In heterozygous Crif1f/+,Fabp4 mice,
hematoxylin and eosin (H&E) staining of adipose tissue showed no
evidence of histological abnormalities compared with the controls
(Figure 1E). Consistent with the results of H&E staining, the
mitochondria of Crif1f/+,Fabp4 mice showed no morphological or
numerical abnormalities of mitochondria in TEM (Figure 1F and
1G). Collectively, this comprehensive analysis of the adipose tissues
in Crif1f/f,Fabp4 mice indicated that loss of Crif1 results in a marked
failure of WAT and BAT development.
Characterization of BAT in Crif1f/f,Fabp4 mice
The Fabp4-Cre transgene is expressed and localized within the
dorsal root ganglion, centrum of the vertebra and the carpals of
the embryo from the mid-gestation stage [19]. Neonatal
Crif1f/+,Fabp4 or Crif1f/f,Fabp4 mice did not show developmental
abnormalities when compared with control mice. Therefore,
embryonic expression of the Fabp4-Cre transgene may not affect
the development of Crif1f/+,Fabp4 and Crif1f/f,Fabp4 mice, and may
not be a plausible reason for observed lethality at around post-
natal Week 3. Mice are normally weaned at post-natal Week 3, at
which point the rate of lipogenesis and UCP1 expression in the
BAT rises sharply and reaches maximal levels to enhance
thermogenesis [20]. The Fabp4-Cre transgene was uniformly
detected in BAT from the early post-natal period (Day 7), the
Author Summary
Type 2 diabetes is one of the most challenging health
problems in the 21st century. Although insulin resistance is
regarded as a fundamental defect that precedes the
development of type 2 diabetes, the nature and cause of
insulin resistance remain unknown. Adipose tissue is an
important organ that determines whole-body energy
metabolism, and its dysfunction is a critical element in the
development of systemic insulin resistance. Adipose mito-
chondrial function is suppressed in the insulin-resistant
state, and increased adipose mitochondrial biogenesis is
associated with the reversal of insulin resistance by a PPARc
agonist. However, despite these important observations,
little is known about how mitochondrial respiratory
dysfunction in white adipose tissue (WAT) causes insulin
resistance. To determine whether adipose deficiency of
mitochondrial respiratory capacity plays an etiological role
in systemic insulin resistance, the metabolic phenotype of
mice with mitochondrial OXPHOS (oxidative phosphoryla-
tion)–deficient adipose tissue was examined. Crif1 is a
protein required for the translation of mtDNA–encoded
OXPHOS subunits. Interestingly, mice haploinsufficient for
Crif1 in adipose tissue showed reduced OXPHOS capacity
and developed marked insulin resistance.
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Figure 1. Marked failure of adipose tissue development in Crif1f/f,Fabp4mice.Mice were generated by breeding two mouse lines, a Crif1flox/flox
transgenic mouse line and a Fabp4-Cre recombinase transgenic mouse line. Data from Crif1f/f,Fabp4 mice were obtained at 3 weeks-of-age. (A) Gross
characteristics of control mice (Crif1+/+,Fabp4), adipose-specific Crif1 heterozygous mice (Crif1f/+,Fabp4), and adipose-specific Crif1 homozygous knockout
mice (Crif1f/f,Fabp4). TS, testis. (B and C) Body weight and tissue weight relative to control mice (n= 10). Values are means + SD, *p,0.05 versus control
mice. BAT, brown adipose tissue; WAT, white adipose tissue. (D) Crif1f/f,Fabp4 mice showed markedly reduced survival rates after 2 weeks-of-age
(n=20). (E) Hematoxylin & eosin (H&E) staining of perirenal WAT (pWAT). Scale: 100 mm. (F) Transmission electron microscopy (TEM) of subcutaneous
WAT (sWAT) revealed that the mitochondria of Crif1f/f,Fabp4 mice developed swollen cristae (red arrows). L, lipid droplet. Scale: 6,000 nm. (G)
Mitochondria number per area in sWAT (n=10). Values are means + SD. n.s, not significant.
doi:10.1371/journal.pgen.1003356.g001
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Crif1 protein and OXPHOS complex subunits are downregulated
in the BAT of 3-week-old mice (Table S1). As shown in Figure 1C,
Crif1f/f,Fabp4 mice had less BAT at Day 21, but histological
examination of inter-scapular BAT showed normal histological
findings (Figure S2A). Crif1f/f,Fabp4 mice had fewer mitochondria
than control mice, but these were larger in size and were
characteristically disorganized and swollen, suggesting OXPHOS
defects (Figure S2B and S2C). Consistent with these findings,
Crif1f/f,Fabp4 mice showed a low body temperature under ambient
conditions (23uC) and rapidly reached a fatally low rectal
temperature within 5 minutes of immersion in cold water (4uC)
(Figure S2D). However, although the mass of BAT was reduced,
the level of UCP1 expression was not altered in Crif1f/f,Fabp4 mice
(data not shown). When Crif1f/f,Fabp4 mice were housed at
thermoneutrality (30uC), the median survival rate was increased
and mortality was reduced (Figure S2E). This indicates that
thermal stress caused by mitochondrial OXPHOS dysfunction in
BAT following Crif1 ablation may be a critical factor in the
premature death of Crif1f/f,Fabp4 mice.
By contrast, the BAT of Crif1f/+,Fabp4 mice showed normal
development and histological and ultrastructural findings (Figure
S2A–S2C). Furthermore, the response of Crif1f/+,Fabp4 mice (in
terms of core temperature) to a cold environment were identical to
those of control mice (Figure S2D). These results showed that
Fabp4-Cre driven haploinsufficiency of Crif1 may not affect the
physiological function of BAT.
Characterization of mitochondrial OXPHOS function in
Crif1f/+,Fabp4 mice
A previous study revealed that Crif1-deficient (2/D) MEFs
prepared from Crif12/flox mice showed marked OXPHOS defects
due to a profound failure of translation and insertion of the newly-
synthesized OXPHOS polypeptides encoded by the mtDNA. Also,
Crif1 2/D MEFs showed increased anaerobic glycolysis, which
eventually led to accelerated cell death [17]. Similar to Crif1 2/D
MEFs, loss of Crif1 in adipose-derived stem cells (ADSCs) (Crif1M2/
2) resulted in marked impairment of differentiation and accelerated
cell death, which prevented functional analysis of the mitochondria
(data not shown). However, control (Crif1+/+) and Crif1-haploinsuf-
ficient ADSCs (Crif1+/2) prepared from Crif1+/+,Fabp4 and
Crif1f/+,Fabp4 mice showed identical levels of cell viability and
differentiation to those of control cells (Figure 2A and 2B). Interestingly,
Crif1+/2 ADSCs showed lower expression of OXPHOS subunits
(ND1, NDUFA9, UQCRC2 and COX4) and assembled OXPHOS
complex I on Western blot and Blue Native PAGE (BN-PAGE)
analysis, respectively (Figure 2C and 2D). Crif1+/2 ADSCs consumed
less oxygen under basal conditions and showed reduced maximal
OXPHOS capacity (Figure 2E). Taken together, Crif1 haploinsuffi-
ciency in adipocytes resulted in normal differentiation but reduced
genetically-determined OXPHOS capacity.
Several experimental criteria have been proposed to test
whether a primary in vivo OXPHOS deficiency plays a causal
role in insulin resistance [21]. One of these criteria is that
perturbations in OXPHOS gene expression and function must be
as modest as possible [21]. Thus, we analyzed Crif1 and OXPHOS
gene expression to test whether Crif1f/+,Fabp4 mice were suitable for
our proposed experiments. Compared with Crif1+/+,Fabp4 mice,
Crif1f/+,Fabp4 mice showed about ,50% of the Crif1 mRNA and
protein expression in epididymal WAT (eWAT) (Figure 2F and
2H). Although basal ATP levels in eWAT were not affected by
Crif1 haploinsufficiency (Figure 2G), the expression levels of
OXPHOS complex I, III and IV subunits were reduced in the
epididymal fat pads of Crif1f/+,Fabp4 mice (Figure 2H). BN-PAGE
analysis showed that the levels of Complex I and IV and
supercomplex in WAT were approximately 20%, 40% and 50%
lower, respectively, in Crif1f/+,Fabp4 mice compared to control mice
(Figure 2I and 2J). However, normal levels of Crif1 and OXPHOS
complexes were expressed in the liver and heart of Crif1f/+,Fabp4
mice (Figure S3A–S3C). In contrast to homozygous Crif1f/f,Fabp4
mice, heterozygous Crif1f/+,Fabp4 mice exhibited normal levels of
OXPHOS subunits in BAT and mitochondrial morphology was
normal (Figure 2H–2J and Figure S2B).
Food intake and weight gain were comparable in Crif1f/+,Fabp4
and Crif1+/+,Fabp4 mice when fed a normal chow diet (NCD)
(Figure S4A and S4B). MR images of control and Crif1f/+,Fabp4
mice fed a NCD or a HFD showed a similar pattern of adipose
distribution (Figure S4C). Triglyceride levels in the liver and
plasma of Crif1f/+,Fabp4 mice were the same as those in control
mice, regardless of whether they were fed a NCD or a HFD.
Serum free fatty acid (FFA) levels tended to be higher in
Crif1f/+,Fabp4 mice, but were not significantly different from those
in control mice (Figure S4D–S4F). Taken together, these results
show that Crif1f/+,Fabp4 mice have mildly reduced primary
OXPHOS deficiency in adipose tissue but, unlike the lipody-
strophic model, they show no defects in adipose tissue develop-
ment, and no hyperlipidemia or ectopic lipid accumulation.
Insulin resistance in Crif1f/+,Fabp4 mice
To identify the relationship between insulin resistance and
reduced OXPHOS capacity in adipocytes in vivo, control and
Crif1f/+,Fabp4 mice were subjected to glucose tolerance tests after 8
weeks or 14 weeks on a NCD or HFD. Neither control nor
Crif1f/+,Fabp4 mice fed a NCD for 8 weeks showed any differences in
glucose tolerance following an intraperitoneal injection of glucose
(IPGTT, 2 g/kg body weight) (Figure 3A). However, Crif1f/+,Fabp4
mice fed a NCD for 14 weeks developed glucose intolerance
(Figure 3B). More impressively, Crif1f/+,Fabp4 mice fed a HFD for 8
weeks showed an earlier onset of glucose intolerance, which was
characterized by higher peak glucose levels than those measured in
control mice in the intraperitoneal glucose tolerance tests (Figure 3C).
Crif1f/+,Fabp4 mice fed a HFD for 14 weeks showed more advanced
glucose intolerance, with higher basal (168.8613.2 mg/dL vs
131.368 mg/dL) and peak (516.8634.8 mg/dL vs 420.46
52.3 mg/dL) plasma glucose levels (Figure 3D). Therefore, regard-
less of the caloric state, mice with Crif1 haploinsufficiency showed
reduced glucose tolerance. Crif1f/+,Fabp4 mice fed a HFD for 14 weeks
showed decreased Akt phosphorylation in the liver and muscle and a
reduced glucose disposal rate after an intraperitoneal insulin challenge
(Figure 3E and 3F). Furthermore, suppression of hepatic glucose
production (HGP) by insulin was not different between the two groups,
but the glucose infusion rate (GIR) and glucose uptake rate decreased
by approximately 18.6% and 14.7%, respectively, during hyperinsu-
linemic euglycemic clamping after 14 weeks on a HFD (Figure 3G);
these data supported the insulin tolerance tests (ITT) results. These
findings indicate that Crif1f/+,Fabp4 mice, which have limited OXPHOS
capacity in their adipose tissue, may show exacerbated diabetic
mechanisms, which are characterized by insulin resistance.
The levels of saturated fatty acids and ceramides in WAT,
muscle and liver were not significantly altered in Crif1f/+,Fabp4 mice
(Figure S4G and S4H). Thus, abnormal accumulation of
ceramides and saturated fatty acids in insulin sensitive tissues does
not appear to underlie the insulin resistance of Crif1f/+,Fabp4 mice
(Figure S4G and S4H).
Dysregulation of chemokines in Crif1-deficient
differentiated adipocytes in vitro
To determine the molecular pathways that are dysregulated by
mitochondrial OXPHOS dysfunction following Crif1 knockdown
Adipose OXPHOS Deficiency and Insulin Resistance
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Figure 2. Dysfunctional mitochondria in Crif1 haploinsufficient adipocytes. (A) Adipose derived stem cells (ADSCs) were isolated from
eWAT of Crif1+/+,Fabp4 and Crif1f/+,Fabp4 mice. The number of Crif1+/+ and Crif1+/2 ADSCs was counted in 96 well plates after 10 days of differentiation
(n=6). Values are means + SD. n.s, not significant. (B) Oil red O staining of Crif1+/+ and Crif1+/2 ADSCs. (C) OXPHOS complex subunits were detected
Adipose OXPHOS Deficiency and Insulin Resistance
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by siRNA in adipocytes, we introduced Crif1 siRNA into fully-
differentiated 3T3-L1 cells. Crif1 knockdown in differentiated 3T3-
L1 cells resulted in decreased expression of the OXPHOS
subunits, ND1, NDUFA9, UQCRC2 and ATP5A1, but did not
affect the expression of Ppar-gamma, adiponectin, and Cd36
(Figure 4A). A complementary DNA (cDNA) microarray analysis
showed prominent increases in the expression levels of inflamma-
tory cytokine and chemokine genes in adipocytes following
knockdown of Crif1 (Figure S5). In particular, the chemokines
monocyte chemotactic protein 1 (Mcp1/Ccl2), IFN-c-inducible
protein (Ip10/Cxcl10), Regulated upon Activation, Normal T cell
Expressed and Secreted (Rantes/Ccl5) and Mig/Cxcl9, which are
important for the recruitment of macrophages and T cells to
WAT, were elevated in Crif1-silenced 3T3-L1 adipocytes [22].
The elevation of Mcp1, Ip10, and Rantes expression observed in
cDNA microarrays was confirmed by real-time PCR experiments
with Crif1-silenced 3T3-L1 adipocytes (Figure 4B). In parallel
experiments, levels of mitochondrial and cytoplasmic superoxide
anions were increased in Crif1-silenced 3T3-L1 adipocytes
compared to control cells (Figure 4C). Treatment with the
antioxidant N-acetylcysteine (NAC) suppressed the expression of
Mcp1, Ip10 and Rantes in Crif1-silenced 3T3-L1 adipocytes
(Figure 4D).
Adipose inflammation links adipocyte dysfunction to insulin
resistance, which are frequently observed in excessive adiposity (for
a review, see). The inflammatory process in adipose tissue is
provoked by the activation of stress kinases, e.g., c-Jun N-terminal
kinase (JNK), which inhibit insulin signaling and activate
transcription factors that mediate the expression of chemokine
genes [24,25]. Intracellular stress signals including mitochondrial
ROS, FFA, ceramide and ER stress activates the stress kinases,
JNK, p38 MAPK and NF-kB in adipocytes [4,26,27]. JNK
mediates macrophage activation and expression of proinflamma-
tory cytokines and inhibits insulin receptor substrate 1 (IRS-1)-
mediated insulin signaling pathways (for a review, see [28,29]). To
identify the roles of stress kinases in the expression of chemokines
in Crif1-silenced 3T3-L1 adipocytes, p38 MAPK and JNK
phosphorylation were observed by Western blot analysis. Levels
of phosphorylated p38 MAPK and JNK were elevated in Crif1-
silenced 3T3-L1 adipocytes compared to control cells; however,
this activation was suppressed by NAC treatment (Figure 4E).
These results indicate that chemokine dysregulation is associated
with increased ROS generation and inappropriate activation of
p38 MAPK and JNK. To confirm these results, 3T3-L1 cells were
treated with inhibitors of p38 MAPK and JNK (SB203580 and
SP60125, respectively). Two inhibitors effectively inhibited the
expression of Mcp1 in Crif1 silenced 3T3-L1 cells (Figure 4F). Crif1
deficiency in MEFs results in increased ROS production [17] and
induces phosphorylation of p38 (Figure S6A). However, Crif1 -/D
MEFs did not show increased Mcp1 and Ip10 expression (Figure
S6B). Taken together, these results suggest that limited mitochon-
drial OXPHOS function in fully-differentiated adipocytes triggers
the expression of chemokines (Mcp1, Ip10 and Rantes) in a cell-
specific manner.
The chemokines (Mcp1, Ip10 and Rantes) upregulated in Crif1
siRNA-treated adipocytes are thought to be critical for attracting
macrophages and T lymphocytes into adipose tissue in obese
subjects [30]. Therefore, we wondered whether Crif1-silenced
3T3-L1 cells would trigger the migration of macrophages. As
shown in Figure 4G, Crif1-silenced 3T3-L1 cells enhanced the
migration of RAW 264.7 cells and NAC treatment inhibited the
migration of RAW 264.7 cells. Thus, our in vitro studies show that
OXPHOS deficiency induced in differentiated cultured 3T3-L1
adipocytes by Crif1 silencing results in the upregulated expression
of chemokines, which then recruit or activate macrophages, ROS
and stress kinase dependently.
Macrophage infiltration and systemic inflammatory
responses in Crif1f/+,Fabp4 mice
To observe ROS stress associated with abnormal chemokine
responses in adipose tissues in vivo, we measured lipid peroxidation
(TBAR assays), stress kinase activation and cytokine expression in
WAT of Crif1f/+,Fabp4 mice fed a NCD or a HFD for 8 weeks.
Consistent with the in vitro studies, lipid peroxidation in WAT and
plasma was increased in Crif1f/+,Fabp4 mice fed a HFD for 8 weeks
compared to control mice (Figure S7A). Levels of p38 MAPK and
JNK phosphorylation were higher in WAT of Crif1f/+,Fabp4 mice
fed a HFD for 8 weeks than in control mice (Figure 5A).
Furthermore, the expression of Mcp1, Ip10 and Rantes was higher
in adipose tissue from Crif1f/+,Fabp4 mice than in control mice
(Figure 5B). In addition, the level of secreted MCP1, but not IP10,
were higher in the serum of Crif1f/+,Fabp4 mice than in control mice
(Figure S7B). The results showing dysregulation of chemokines in
the absence of Crif1 suggest that mitochondrial OXPHOS
dysfunction may trigger immune cell recruitment in adipose tissue.
To observe inflammation in the adipose tissue of Crif1f/+,Fabp4
mice directly, the eWAT were stained with anti-F4/80, an
antibody that detects macrophages. Increased F4/80 reactivity
was observed in the eWAT of Crif1f/+,Fabp4 mice fed a NCD for 8
weeks. Aging and a HFD had an even more pronounced effect
(Figure 5C). Based on the quantitative real-time PCR results, the
relative expression of proinflammatory M1 macrophage markers
(Cd11c, Cd11b and Tnfa) increased significantly; however, the
relative gene expression of an anti-inflammatory M2 macrophage
marker (arginase 1) did not change (Figure 5D). To quantify the
number of macrophages in the adipose tissue, multi-parameter
flow cytometry was performed with anti-F4/80, anti-CD11c and
anti-CD206 antibodies using isolated stromal vascular fractions
(SVF). F4/80+/CD11c+/CD206- M1 macrophages were pre-
dominant in Crif1f/+,Fabp4 mice compared with control mice. The
proportion of F4/80+/CD11c-/CD206+ M2 macrophages tend-
ed to be higher in Crif1f/+,Fabp4 mice, but this did not reach
statistical significance (Figure 5E). Taken together, the results
suggested that the infiltrating macrophages were skewed towards
the M1 phenotype in Crif1f/+,Fabp4 mice. Recent studies show that
B cell-mediated CD4+ and CD8+ T cell activation is required to
induce inflammation and insulin resistance [31,32]. The present
by western blotting with the appropriate antibodies. Anti-ND1 and anti-NDUFA9 were used to detect OXPHOS complex I, anti-UQCRC2 was used for
complex III, and anti-COX4 was used for complex IV. (D) BN-PAGE analysis using a mixture of anti-OXPHOS antibodies to detect assembled OXPHOS
complexes. (E) Oxygen consumption rates (OCR) measured by Seahorse XF-24 flux analyzer in Crif1+/+ and Crif1+/2 ADSCs (n= 6). Values are means
6 SD, *p,0.05. CCCP, carbonyl cyanide m-chloro phenyl hydrazine. (F) Crif1 mRNA expression in eWAT, BAT, liver and heart of Crif1+/+,Fabp4 and
Crif1f/+,Fabp4 mice (n=8). Values are means + SD, *p,0.05. (G) Level of ATP in eWAT of Crif1+/+,Fabp4 and Crif1f/+,Fabp4 mice (n= 8). Values are means +
SD. n.s, not significant. (H) Western blots analysis of Crif1 and OXPHOS subunits from eWAT and BAT of mice. ND1 and NDUFA9, subunit of OXPHOS
complex I; UQCRC2, subunit of OXPHOS complex III; COX4, subunit of OXPHOS complex IV. (I) BN-PAGE analysis of assembled OXPHOS complexes (I,
II, III, IV and V). Percentage of band intensities are presented in the graph (n=4). Values are means + SD, *p,0.05. (J) BN-PAGE analysis of
supercomplex (I+III2+IV1–4, I+III2, III2+IV and III2).
doi:10.1371/journal.pgen.1003356.g002
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Figure 3. Metabolic phenotypes and insulin resistance in Crif1f/+,Fabp4 mice. (A–D) An intraperitoneal glucose tolerance test (IPGTT) was
performed with 1 g/kg glucose, after a 16 h fast in NCD or HFD mice (n=8). Values are means 6 SD, *p,0.05 versus control mice. (E) Western blot
analysis of p-Akt in the gastrocnemius muscle and liver after injecting 1 U/kg insulin in control and Crif1f/+,Fabp4 mice with 14 weeks of HFD. Data are
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study found no difference between the numbers of CD4+ and
CD8+ T cells in Crif1+/+,Fabp4 and Crif1f/+,Fabp4 mice (data not
shown).
Adipocytes in adipose tissue secretes adipokines, such as
adiponectin, leptin, IL-6 and TNFa, which are involved in the
control of whole-body insulin sensitivity. However, proinflamma-
tory TNFa is released by dysfunctional adipocytes and amplifies
local immune responses by recruiting macrophages to WAT
[33,34]. Serum levels of TNFa were consistently higher in
Crif1f/+,Fabp4 mice fed a HFD than in control mice (Figure 5F).
This indicates that TNFa may be a crucial mediator of
inflammation in WAT and whole-body insulin resistance of
Crif1f/+,Fabp4 mice.
The Fabp4 gene is expressed in macrophages [35], but no Cre
expression or activity was detected in macrophages isolated from
Crif1f/+,Fabp4 mice. As shown in Figure S8A, the expression levels of
Crif1 and macrophage markers (Cd11c, Tnfa, Cd11b, and Arg1)
were not reduced in peritoneal macrophages obtained from
Crif1f/+,Fabp4 mice (Figure S8A). Homologous recombination using
PCR [36] identified Cre recombinase activity in WAT and BAT,
but not in peritoneal macrophages in Crif1f/+,Fabp4 mice at 20
weeks-of-age (Figure S8B and S8C).
Adipose inflammation and glucose intolerance in
Crif1f/f,Adipoq mice
To verify the adipose inflammation characterized by macro-
phage infiltration in Crif1-null mice, we generated another adipose
tissue-specific Crif1 knockout mouse by crossing floxed Crif1 mice
with Adipoq-Cre transgenic mice. Adipoq-Cre transgenic mice
expressed Cre recombinase in WAT and BAT, but not in
macrophages (including adipose tissue resident macrophages,
alveolar macrophages, or thioglycolate-stimulated peritoneal
macrophages) [37].
The homozygous Crif1 knockout mice (Crif1f/f,Adipoq) showed
about ,30% of the Crif1 expression observed in the eWAT of
controls (Figure S9A). They showed decreased expression of
OXPHOS subunits (ND1, NDUFA9, UQCRC2 and COX4) in
eWAT and BAT, not in liver and heart (Figure S9B). We
compared adipocyte development in the adipocyte-specific Crif1
knockout mouse with that of Adipoq-Cre mice. H&E staining of
adipose tissues indicated that the adipocytes of Crif1f/f,Adipoq mice
were relatively smaller and irregularly shaped in comparison to
those of Crif1+/+,Adipoq mice (data not shown).
Consistent with the Crif1f/+,Fabp4 mouse model, Crif1f/f,Adipoq mice
showed higher plasma levels of MCP1 (1.9-fold higher), IP10 (2.5-
fold higher) and marked F4/80 immuno-reactivities in eWAT,
suggesting inflammation in WAT (Figure 6A and 6B). The nature
of the macrophage phenotypes was further identified by flow
cytometry using fluorescently-labeled anti-F4/80, anti-CD11c,
and anti-CD206 antibodies. In addition, the T cell population was
also analyzed using anti-CD3, anti-CD8, and anti-CD4 antibod-
ies. Crif1f/f,Adipoq mice had a higher level of M1 macrophages and a
lower level of M2 macrophages in eWAT compared to
Crif1+/+,Adipoq mice (Figure 6C). The level of cytotoxic CD8-
positive T cells was increased 5.5-fold and the level of CD4-
positive helper T cells was decreased 0.5-fold in Crif1f/f,Adipoq in
comparison to control mice; however, the levels of these cells in
Crif1f/+,Fabp4 mice were not significantly different from control mice
(Figure 6D). This reflect differences in the severity of the defect in
the mitochondrial OXPHOS complex in Crif1f/f,Adipoq and Crif1f/
+,Fabp4mice. Similar to Crif1f/+,Fabp4 mice, Crif1f/f,Adipoq mice
developed glucose intolerance even in being fed a NCD, at 8
weeks-of-age (Figure 6E).
Unlike Crif1f/f,Fabp4 mice, Crif1f/f,Adipoq mice were viable. This
discrepancy could be due to the inherent differences in the
activities of Cre-recombinase driven by Fabp4 and adiponectin
promoter (Table S1). Loss of Crif1 was consistently observed in
WAT in both mouse lines; however, the degree of Crif1 loss was
more severe in Crif1f/f,Fabp4 mice than in Crif1f/f,Adipoq mice. Also,
Crif1f/f,Fabp4 mice exhibited a severe loss of BAT and WAT mass,
whereas the mass of these tissues was only mildly reduced in
Crif1f/f,Adipoq mice. Consistent with these findings, homozygous
Crif1f/f,Fabp4 mice rapidly reached a fatal low rectal temperature of
22.6+1.9uC (Figure S2D), whereas homozygous Crif1f/f,Adipoq mice
reached a milder rectal temperature of 29.5+0.7uC within
5 minutes of immersion in cold water (4uC) (Figure S9C). These
results indicated that thermal stress caused by mitochondrial
OXPHOS dysfunction in BAT following Crif1 ablation may be a
causative factor of the premature death of adipocyte specific Crif1
knockout mice, and that BAT dysfunction may be partially
involved in systemic glucose intolerance.
Reversal of insulin resistance in adipose-specific Crif1-
deficient mice by clodronate treatment
To determine whether macrophages in the adipose tissue of
Crif1f/+,Fabp4 mice play a role in insulin resistance, we depleted
macrophages from adipose tissue by intraperitoneal treatment
with clodronate liposomes [38]. Clodronate is an apoptosis-
inducing drug; therefore, injection of liposome-encapsulated
clodronate into the intraperitoneal cavity can deplete phagocytic
cells, such as macrophages. Control and Crif1f/+,Fabp4 mice fed a
HFD for 8 weeks were intraperitoneally administered two rounds
of clodronate liposomes with an interval of 3 days. The
accumulation of macrophages positively stained with an anti-F4/
80 antibody was decreased in the eWAT following injection of
clodronate liposomes (Figure 7A). Furthermore, the level of Cd68
mRNA was significantly lower in the eWAT of mice injected with
clodronate than in untreated mice (Figure 7B). Administration of
clodronate liposomes dramatically improved the insulin and
glucose tolerance of Crif1f/+,Fabp4 mice fed a HFD for 10 weeks
(Figure 7C and 7D). These findings indicate that suboptimal
reserves of mitochondrial OXPHOS in the adipose tissue of Crif1-
deficient mice induce macrophage recruitment, which may trigger
systemic insulin resistance (Figure 8).
Discussion
Mitochondrial dysfunction, characterized by reduced OX-
PHOS function in liver and skeletal muscle, is thought to be one
of the underlying causes of insulin resistance and type 2 diabetes
(for a review, see [39,40]). In addition, reduced hepatic OXPHOS
function is closely related to hepatic lipid accumulation and insulin
resistance [41]. Collectively, these studies provide evidence of a
role for mitochondrial OXPHOS dysfunction in the development
of human insulin resistance and type 2 diabetes. However, animal
models of OXPHOS dysfunction in skeletal muscle and liver do
not exhibit the human insulin resistance and type 2 diabetes
representative of three independent experiments. p-Akt, phospho-Akt; t-Akt, total-Akt. (F) Insulin (0.75 U/kg) tolerance tests (ITTs) (n=8). Values are
means 6 SD, *p,0.05 versus control mice. (G) Hyperinsulinemic euglycemic clamp analysis in Crif1+/+,Fabp4 and Crif1f/+,Fabp4 mice with 14 weeks of
HFD. HGP, hepatic glucose production (n=8). Values are means + SD, *p,0.05, n.s, not significant.
doi:10.1371/journal.pgen.1003356.g003
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phenotype [21,42,43]. The absence of insulin resistance in mice
with homozygous or heterozygous Crif1 deletion in the liver
(Crif1f/f,Alb, Albumin-Cre) or skeletal muscle (Crif1f/+,MLC, MLC-Cre)
is in agreement with previous findings that hepatic and skeletal
mitochondrial dysfunction does not cause insulin resistance (Figure
S10). Therefore, whether or how mitochondrial OXPHOS
contributes to the pathogenesis of insulin resistance remains to
be resolved. It is reported that adipose OXPHOS capacity is
controlled by both genetic and diet-induced obesity [10,44,45],
which potentially contribute to adipose tissue dysfunction and
exacerbation of insulin resistance. However, whether changes in
adipose OXPHOS capacity are a cause or a consequence of
complications associated with insulin resistance has not been
clarified in vivo.
In this study, we have shown an association between limited
mitochondrial OXPHOS capacity and adipose tissue inflamma-
tion and insulin resistance in a Crif1 haploinsufficiency animal
model. Mitochondria play a key role in the differentiation and
maturation of adipocytes. It is reported that marked mitochondrial
biogenesis is observed during the adipocyte differentiation process
in vitro. In fact, the concentration of mitochondrial proteins in
differentiated 3T3-L1 adipocytes showed a 20- or 30-fold increase
compared with that in pre-adipocytes [14,46]. Notably, chemical
inhibition of respiratory chain function, for example by rotenone
treatment, suppresses adipogenesis and induces changes in the
expression levels of the key transcription factors, C/EBPa,
PPARc, and SREBP-1c [47]. However, the role played by
mitochondria during adipogenesis has mostly been investigated in
vitro by inhibiting or knocking down the genes encoding the
OXPHOS complex. This study showed that homozygous Crif1
null mice generated by both Fabp4-Cre and Adipoq-Cre recombi-
nase have defects in WAT and BAT development. These
observations support that notion that intact OXPHOS function
is critical for adipogenesis in vivo. By contrast, our own observations
show that heterozygous Crif1 knockout mice do not have defects in
adipogenesis and maturation under NCD and HFD conditions.
This finding indicates that Crif1 haploinsufficiency and mildly
reduced OXPHOS capacity do not cause the apparent failure of
adipogenesis in WAT and BAT. Consistently, plasma and liver
lipid levels were not increased in heterozygous Crif1 knockout
mice, suggesting that the mice do not have the lipodystrophy
phenotype. Furthermore, it is reported that insulin resistance in a
mouse model of lipodystrophy was not relieved by controlling
inflammation [48]. Therefore, insulin resistance in Crif1 haploin-
sufficient knockout mice may not be related to lipodystrophic
changes.
Similar to WAT, the development of BAT was severely
perturbed in homozygous Crif1-null mice (Crif1f/f,Fabp4), which
may be a critical factor in the early mortality of these mice. By
contrast, BAT development was normal in heterozygous
Crif1f/+,Fabp4 mice, and the histology and ultrastructure of
mitochondria were normal. Furthermore, core temperature
responses to a cold environment suggest that Fabp4-Cre-driven
haploinsufficiency of Crif1 may not affect the physiological
function of BAT. Therefore, decreased BAT function and
impaired energy expenditure may not be principal cause of the
development of insulin resistance in Crif1-haploinsufficient mice.
The OXPHOS capacity in adipose tissue may be controlled by
tissue-specific, genetic and environmental factors. In fact, it is well
known that each cell type develops and maintains a specific
OXPHOS capacity to satisfy its metabolic and energetic demands.
In addition, individual OXPHOS capacity is genetically deter-
mined by specific tissues [49]. The cellular and genetic factors that
control adipose-specific OXPHOS capacity are not fully under-
stood. Therefore, white adipocyte responses to marginal or limited
OXPHOS capacity in vitro and in vivo remain to be elucidated. In
the present study, we characterized the enhanced secretory
chemokine responses in Crif1-silenced mature adipocytes. Chemo-
kine production in WAT is physiological, but enhanced produc-
tion is linked to adipose inflammation, which is usually observed in
cases of excessive adiposity (for a review, see [50]). Therefore, the
earliest events that trigger the process of enhanced chemokine
secretion are of great interest. Studies on signals that initiate
adipose inflammation are mainly based on the model of ER
homeostasis, lipolysis, and fatty acid signals in obese individuals
(for a review, see [4]). It is not known how mitochondria or
OXPHOS dysfunction modify the chemokine responses in WAT
under physiological and pathological conditions. We found that
abnormal increases in ROS production and activation of p38 and
JNK were associated with increased expression of Mcp1, Ip10 and
Rantes. The increase in ROS and the activation of p38 and JNK in
adipose tissue are common denominators that respond to cellular
stresses. Unexpectedly, haploinsufficient heterozygous Crif1f/+,Fabp4
mice and control mice exhibited similar levels of adipose Akt
phosphorylation in response to insulin injection. This indicates
that insulin signaling in adipose tissue may not be the principal
cause of the systemic glucose intolerance of Crif1f/+,Fabp4 mice.
Therefore, the relative importance of these factors (increased
ROS, p38 and JNK activation) need to be addressed by
suppressing or eliminating these events while studying abnormal
chemokine responses and systemic insulin resistance.
We showed that the WAT in Crif1-deficient mice is predom-
inantly infiltrated by macrophages, regardless of excessive
adiposity. An increase in the number of adipose tissue macro-
phages (ATM) is a prominent feature associated with excessive
adiposity [51,52]. Increased expression of chemokines, especially
MCP1, is responsible for recruiting macrophages into the WAT
[30]. The ATM infiltration of epididymal fat pads in Crif1-
deficient mice showed several characteristic features. First, it was
present in fat pads with normal adiposity. This finding suggests
that macrophage recruitment to adipose tissue caused by impaired
OXPHOS capacity may also develop independently of excessive
adiposity, but is accentuated in cases of increased adiposity.
Mitochondrial OXPHOS dysfunction in the adipose tissue of
Figure 4. Dysregulation of chemokines and activation of stress kinases in Crif1-deficient 3T3-L1 adipocytes. (A) Silencing of Crif1 and
expression of adipogenic genes, Ppargamma, adiponectin and Cd36 in 3T3-L1 cells. Western blot analysis with anti-ND1 and NDUFA9 (Complex I),
anti-UQCRC2 (Complex III) and anti-ATP5A1 (Complex V) after 4 days of Crif1 silencing (n= 10). siCTR, control siRNA; siCrif1, Crif1 siRNA. Values are
means + SD, *p,0.05. (B) Expression of macrophage recruiting chemokines (Mcp1, monocyte attractant chemokine; Ip10, IFN-c–inducible protein 10;
Rantes, Regulated upon Activation, Normal T cell Expressed and Secreted) by 3T3-L1 cells subjected to Crif1 siRNA (n= 10). Values are means + SD,
*p,0.05. (C) Measurement of MitoSox- or DHE-stained cells by flow cytometry. DHE, di-hydroethidium (n=10). Values are means + SD, *p,0.05. (D)
Mcp1, Ip10 and Rantes mRNA levels with/without NAC treatment (1 mM) for 24 h. NAC, N-acetyl-L-cysteine (n=10). Values are means + SD, *p,0.05.
(E) p-p38 MAPK and p-JNK levels in Crif1-deficient 3T3-L1 adipocytes with/without NAC treatment (1 mM) for 24 h. p38 MAPK, p38 mitogen-activated
protein kinases; JNK, c-Jun N-terminal kinases. (F) Inhibition of Mcp1 expression after treatment with p-p38 (SB203580; 10 mM for 24 h) or p-JNK
(SP60125; 20 mM for 24 h) inhibitors, respectively (n= 10). Values are means + SD, *p,0.05. (G) Migration of Raw264.7 macrophages examined using
culture supernatants from control siRNA- or Crif1 siRNA-treated 3T3-L1 adipocytes with/without NAC (n= 10). Values are means + SD, *p,0.05.
doi:10.1371/journal.pgen.1003356.g004
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Figure 5. Macrophage infiltration and inflammation in adipose tissue of Crif1f/+,Fabp4 mice. (A) Western blotting for p38 MAPK and JNK
phosphorylation in WAT of Crif1f/+,Fabp4 mice fed a HFD for 8 weeks. p38 MAPK, p38 mitogen-activated protein kinase; JNK, c-Jun N-terminal kinase.
(B) Mcp1, Ip10 and Rantes mRNA levels in eWAT from control mice fed a NCD or a HFD for 8 weeks (n= 8). Values are means + SD, *p,0.05 versus
control mice. (C) Immunohistochemistry with anti-F4/80 and hematoxylin staining reveals macrophage accumulation in eWAT. Scale: 200 mm. (D)
Expression of the M1 macrophage and M2 macrophage-specific genes (Cd11c, Cd11b, Tnfa and arginase1) in eWAT (n= 8). Values are means + SD,
*p,0.05 versus control mice, n.s, not significant. (E) Percentage of proinflammatory M1 macrophages and anti-inflammatory M2 macrophages
assessed by counting CD11c-PE-A- and CD206-FITC-stained cells in the SVF in eWAT of 14 weeks HFD feeding mice (n= 8). Values are means + SD,
*p,0.05 versus control mice. MW, Macrophage. (F) Serum IL4 and TNFa levels in mice fed HFD, as measured by Multiplex (n= 8). Values are means +
SD, *p,0.05 versus control mice, n.s, not significant.
doi:10.1371/journal.pgen.1003356.g005
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Figure 6. Recruitment of macrophages and T cells to adipose tissue in Crif1f/f,Adipoq mice. Control (Crif1+/+,Adipoq), adipose-specific Crif1
heterozygous (Crif1f/+,Adipoq), and homozygous (Crif1f/f,Adipoq) knockout mice were generated by cross-breeding with Adipoq-Cre recombinase
transgenic mice. Phenotypic analysis all of these mice fed with a NCD was performed at 8 weeks-of-age. (A) Secreted MCP1 and IP10 levels in the
serum in the three strains of mice (n= 6). Values are means + SD, *p,0.05 versus control mice. (B) Immunohistochemical staining with an anti-F4/80
antibody shows severe macrophage accumulation in eWAT of Crif1f/f,Adipoq mice. Scale: 200 mm. (C) Percentage of proinflammatory M1 macrophages
(CD11c-PE-A-) and anti-inflammatory M2 macrophages (CD206-FITC-) (n= 6). Values are means + SD, *p,0.05. MW, Macrophage. (D) Percentage of
CD8 positive T cells and CD4 positive T cells in the SVF in eWAT. Quantification of the CD8/CD4 ratio by counting cells stained with CD8-FITC and CD-
PE-cy7 (n= 6). Values are means + SD, *p,0.05. (E) IPGTT was performed in NCD mice after a 16 h fast with 1 g/kg of glucose (n= 6). Values are means
6 SD, *p,0.05 versus control.
doi:10.1371/journal.pgen.1003356.g006
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Figure 7. Depletion of macrophages in adipose tissue by clodronate. The clodronate study was performed after feeding Crif1+/+,Fabp4 and
Crif1f/+,Fabp4 mice a HFD for 8 weeks. Two intraperitoneal injections of clodronate were given with a 3 day interval between each. IPGTT and ITT were
performed 6 days after the first injection. (A) Immunohistochemistry with anti-F4/80 after macrophage depletion by liposomal clodronate in
Crif1+/+,Fabp4 and Crif1f/+,Fabp4 mice fed HFD. Scale: 200 mm. (B) Real-time PCR using primers for the macrophage marker, Cd68 (n= 8). Values are means
+ SD, *p,0.05. (C and D) IPGTT and ITT after macrophage depletion by intraperitoneal injection of liposomal clodronate or PBS control (n= 8). Values
are means + SD, *p,0.05, Crif1f/+,Fabp4 mice versus control mice; + p,0.05, clodronate versus PBS in control mice.
doi:10.1371/journal.pgen.1003356.g007
Figure 8. A model of the systemic insulin resistance developed by Crif1-haploinsufficient mice, which shows limited adipose
OXPHOS capacity.
doi:10.1371/journal.pgen.1003356.g008
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Crif1f/+,Fabp4 mice fed a NCD for 8 weeks resulted in macrophage
recruitment; however, the mice showed normal glucose tolerance.
This suggests that a threshold level of macrophage recruitment or
activation is required for the development of insulin resistance.
Phenotypic analysis of ATM in Crif1-deficient mice demonstrated
that the proportion of both M1 and M2 macrophages tended to be
increased under NCD and HFD conditions. However, a
phenotypic shift toward M1 macrophages was observed in the
adipose tissue of Crif1-deficient mice. Thus, these features of
macrophage recruitment in WAT were similar to those observed
in a mouse model of diet-induced obesity [53].
Our data provide novel insights into the relationship between
adipose inflammation and insulin resistance. This study supports
the idea that adiposity overwhelms the genetically-determined
OXPHOS capacity in adipose tissue, provoking an inflammatory
response and insulin resistance. Therefore, it is possible that
adipose mitochondrial OXPHOS capacity is an independent
factor determining the risk of adipose inflammation and systemic
insulin resistance in obese and even in non-obese subjects.
Materials and Methods
Cell culture
3T3-L1 cells were maintained in Dulbecco’s modified Eagle’s
medium (DMEM) supplemented with 10% bovine calf serum
(Gibco BRL). Forty-eight hours post-confluence, the cells were
differentiated with IBMX (0.5 mM), dexamethasone (1 mM),
insulin (10 mg/ml) and 10% fetal bovine serum (Gibco BRL)
[54]. Crif1 siRNA (GGA GUG CUC GCU UCC AGG AAC
UAU U) was transfected by using Lipofectamine RNAiMAX
reagent (Invitrogen) into 3T3-L1 adipocytes on day 4 of
differentiation. Migration of Raw264.7 cells was examined in
8.0 mm Transwell filters (Corning Corp). Raw 264.7 cells were
maintained on the top well, with the media from 3T3-L1
adipocytes in the bottom well. After twenty-four hours, the Raw
264.7 cells that had not migrated to the filter were removed, and
the cells that had migrated through the filter were collected and
stained with trypan-blue. ADSCs were cultured as previously
described [55]. ADSCs were differentiated into adipocytes using
IBMX (0.5 mM), dexamethasone (1 mM), insulin (10 mg/ml) and
rosiglitazone (0.5 mM) in M199 medium (Gibco BRL) supple-
mented with 10% fetal bovine serum (Gibco BRL). After induction
of differentiation, lipid accumulation was detected with Oil red O
staining. ADSCs were fixed with 10% neutralized formalin,
washed with water, and then stained with freshly prepared 0.2%
Oil red O solution.
Western blot analysis
Primary antibodies against OXPHOS complex subunits
(NDUFA9, SDHA, UQCRC2, and ATP5A1) were purchased
from Invitrogen. Anti-COX4 (#4844) antibody was purchased
from Cell Signaling. Anti-ND1 antibody (sc-65237) was purchased
from Santa Cruz Biotechnology. Secondary antibodies (goat anti-
mouse and goat anti-rabbit) were obtained from Cell Signaling.
Anti-p38 antibody, anti-phospho-p38 antibody, anti-JNK-anti-
body, anti-phospho-JNK antibody, anti-phospho-Akt and total-
Akt antibodies were obtained from Cell Signaling and anti-b-actin,
a-tubulin antibody was obtained from Sigma-Aldrich. Anti-UCP1
antibody was obtained from Abcam.
Northern blot analysis and real-time PCR
Total RNA was isolated using Trizol (Invitrogen). For Northern
blot analysis, 10–20 mg of total RNA was loaded onto a 1.5%
agarose-formaldehyde gel. A Crif1 probe was constructed using the
mouse Crif1 gene digested with KpnI enzyme. The relative
intensity of the Crif1/b-actin bands was normalized against that in
the brain. Complementary DNA (cDNA) was prepared from total
RNA using M-MLV Reverse Transcriptase and oligo-dT primers
(Invitrogen). Real-time PCR was performed using cDNA,
QuantiTect SYBR Green PCR Master Mix (QIAGEN), and
specific primers. The primers used are described in Table S2.
Relative expressions were calculated normalized with 18s
ribosomal RNA, using Rotor-Gene 6000 real-time rotary analyzer
Software (Version 1.7, Corbett Life Science).
Complementary DNA microarray analysis
Total RNA was prepared from fully-differentiated 3T3-L1
adipocytes transfected with control or Crif1 siRNA. RNA
amplification and labeling were performed with the Low RNA
Input Linear Amplification kit PLUS (Agilent Technologies).
Array hybridization and scanning were performed with a DNA
microarray Chip and scanner (Agilent Technologies). Array data
was analyzed using the Feature Extraction and GeneSpring
Software (Agilent Technologies).
ROS staining
Dihydroethidium (DHE) or MitoSOX were used to detect
intracellular superoxide. Fully-differentiated 3T3-L1 cells were
incubated with 10 mM DHE or 5 mM MitoSOX at 37uC for
15 min. Fully-differentiated 3T3-L1 cells were washed with Krebs-
HEPES buffer (pH 7.4) or HBSS. Images of cells stained with
DHE or MitoSOX were obtained by fluorescence microscopy
(Olympus, Japan). Cells were trypsinized and analyzed using a
FACScan flow cytometer (BD Bioscience) and data analysis was
performed using BD FACSDiva software (BD Bioscience).
Blue native-polyacrylamide gel electrophoresis (BN-
PAGE)
Before BN-PAGE, mitochondrial isolation was performed as
previously described [56] with modifications. Pellets of ADSCs or
tissues from mice were resuspended in buffer B (210 mM
mannitol, 70 mM sucrose, 1 mM EGTA, and 5 mM HEPES,
pH 7.2) and incubated for 5 min at 4uC. After centrifugation at
6006g for 10 min, the supernatant was re-centrifuged at 17,0006
g for 10 min. The pellet containing the mitochondrial fraction was
used in the Native PAGE Novex Bis-Tris Gel system (Invitrogen)
to determine the content of the OXPHOS complex. A total of
20 mg of the mitochondrial fraction in Native PAGE sample buffer
supplemented with 0.5% n-dodecyl-b-D-maltoside was loaded
onto a Native PAGE Novex 3–12% Bis-Tris gel. The mitochon-
drial fraction was mixed with Native PAGE sample buffer
containing 1% of digitonin to detect the supercomplexes. After
electrophoresis, the separated proteins in the gel were transferred
to a PVDF membrane, which was then incubated with an anti-
OXPHOS antibody mixture (Invitrogen).
Oxygen consumption rate (OCR)
OCR was measured using a Seahorse XF-24 analyzer (Seahorse
Bioscience). Control Crif1+/+ and Crif1+/2 ADSCs were
prepared from the eWAT of Crif1+/+,Fabp4 and Crif1f/+,Fabp4 mice.
After seeding ADSCs on an XF-24 plate, cells were incubated in
differentiation M199 media contained with FBS, IBMX, dexa-
methasone, insulin and rosiglitazone. After 2 days later, Crif1+/+
and Crif1+/2 ADSCs maintained M199 media with insulin for 8
days. The day before OCR measurement, the sensor cartridge was
calibrated with calibration buffer (Seahorse Bioscience) at 37uC.
Fully-differentiated ADSCs were washed and incubated with
Adipose OXPHOS Deficiency and Insulin Resistance
PLOS Genetics | www.plosgenetics.org 14 March 2013 | Volume 9 | Issue 3 | e1003356
M199 (Gibco BRL) without sodium bicarbonate at 37uC in an
incubator. Three readings were taken after each addition of
mitochondrial inhibitor before injection of the subsequent
inhibitors. The mitochondrial inhibitors used were oligomycin
(2 mg/ml), carbonyl cyanide m-chloro phenyl hydrazine (CCCP,
10 mM), and rotenone (1 mM). OCR was automatically calculated
and recorded by the sensor cartridge and Seahorse XF-24
software. The plates were saved and the protein concentration
was calculated to confirm that there were an approximately equal
number of cells in each well.
Mice
Floxed Crif1 (Crif1flox/flox) mice were generated as previously
described [18]. Fabp4-Cre, Albumin-Cre transgenic mice (C57BL/
6J) were purchased from the Jackson Laboratory. Adiponectin-Cre
transgenic mice were kindly provided by Dr. Evan Rosen. Dr.
Steven J Burden provided the MLC-Cre mouse strain. The HFD,
which contained 60% fat, was purchased from Research Diets Inc.
(D12492). Mice were maintained in a controlled environment
(12 h light/12 h dark cycle; humidity 50–60%; ambient temper-
ature 23uC61uC) and fed ad libitum. For the cold challenge
experiments, mice were individually housed in cages pre-chilled to
4uC. Body temperature was monitored using a rectal probe
attached to a digital thermometer (TD-300, Shibaura Denshi.
Japan) with/without cold stress. For the thermoneutrality exper-
iments, 2-week-old mice were housed with their mothers at a
temperature of 30uC61uC. All mouse experiments were per-
formed in the animal facility according to institutional guidelines,
and the experimental protocols were approved by the institutional
review board of Korean Research Institute of Biotechnology and
Bioscience, and Chungnam National University.
Genomic PCR
To measure the activity of Cre recombinase, PCR was
performed as previously reported [36]. Briefly, after isolation of
genomic DNA from WAT, BAT, and thioglycolate-induced
peritoneal macrophages, PCR was performed with a combination
of three primers: forward primer 1, GGGCTGGTGA
AATGTGTTG; reverse primer 2, TCAGCTAGGG TGGGA-
CAGA; and reverse primer 3, TATCAGTCCG AGAA-
GACCTG. To ensure product specificity from PCR, the extension
time was limited to 30 sec.
Histological and morphometric analysis
WAT was fixed in 10% neutralized formalin for 16 h, washed,
and then embedded in paraffin. Tissue sections of 5 mm thickness
were deparaffinized, rehydrated, and heated in a microwave for
10 min in citrate buffer. The tissue sections were then incubated
with primary antibodies (anti-F4/80 (diluted 1:100; Abcam)) for
16 h at 4uC. Immunohistochemistry was performed using a
Polink-1 HRP Rat-NM DAB Detection System (GBI Inc).
Transmission electron microscopy (TEM)
WAT and BAT were fixed in 1% glutaraldehyde at 4uC and
then washed with 0.1 M cacodylate buffer at 4uC. After washing
five times, the tissue was post-fixed with 1% OsO4 in an 0.1 M
cacodylate buffer (pH 7.2) containing 0.1% CaCl2 for 1 h at 4uC.
Samples were dehydrated by serial ethanol and propylene oxide
treatment and embedded in Embed-812 (EMS). The resin was
then polymerized at 60uC for 36 h. Tissue was sectioned using an
EM UC6 ultramicrotome (LEICA) and stained with 4% uranyl
acetate and citrate. Observation was performed using a Tecnai G2
Spirit Twin transmission electron microscope (FEI Company,
USA) and a JEM ARM 1300S high-voltage electron microscope
(JEOL, Japan).
Intraperitoneal glucose tolerance (IPGTT) and insulin
tolerance tests (ITT)
For IPGTT, mice were fasted for 16 h and then 2 g/kg or 1 g/
kg glucose was injected into the intraperitoneal cavity of each
mouse. Blood glucose levels were measured at 0, 15, 30, 60, and
90 min using a glucometer (Bayer breeze). ITT was performed by
measuring blood glucose after 6 h of fasting followed by
intraperitoneal insulin injection (0.75 U/kg; Humalog).
Hyperinsulinemic euglycemic clamping
Hyperinsulinemic euglycemic clamping was performed as
previously described [57]. Briefly, after an overnight fast, a 2 h
hyperinsulinemic euglycemic clamping was performed in
Crif1f/+,Fabp4 and control littermates (n= 8). The insulin clamp
began with a primed-continuous infusion of insulin (0.3 U/kg
bolus followed by 2.5 mU/kg/min). Blood samples (20 ml) were
collected at 10 to 20 min intervals for immediate measurement of
plasma glucose concentrations, and 20% glucose was infused at
variable rates to maintain glucose at basal concentrations
(,120 mg/dL). Basal and insulin-stimulated whole-body glucose
uptake was estimated with a continuous infusion of 3H glucose
(Perkin Elmer Life and Analytical Sciences) for 2 h before
clamping (0.05 mCi/min) and throughout the clamping (0.1 mCi/
min), respectively. At 75 min after the start of the clamp, 2-
deoxy-d-1-14C glucose (PerkinElmer Life and Analytical Sciences)
was injected with a Hamilton syringe to measure insulin-
stimulated glucose transport activity and metabolism in skeletal
muscle. Blood samples were taken before, during, and at the end
of the clamps for measurement of plasma 3H glucose and 2-
deoxy-d-1-14C glucose concentrations, and/or insulin concentra-
tions. At the end of the clamps, tissue samples (gastrocnemius,
eWAT, and liver) were rapidly taken and stored at 270uC prior
to biochemical and molecular analysis.
Flow cytometry
To quantified M1 macrophages, M2 macrophages, and CD4+
and CD8+ T cell populations, the stromal vascular fractions
(SVF) was isolated from mouse eWAT. The SVF was prepared
by the lysis of eWAT with type 1 collagenase (Gibco BRL) in
collagenase buffer at 37uC in a shaking water bath for 40 min,
followed by centrifuging at 2000 rpm for 5 min. The suspended
solid matter comprised adipocytes and the cell pellet comprised
T cells, B cells and macrophages. The cell pellet was then
incubated with RBC lysis buffer and the remaining cells were
stained with specific antibodies. Anti-CD3 (BD bioscience), anti-
CD4 (BD Bioscience) and anti-CD8 (eBioscience) were used to
stain the T cell population [58], and F4/80 (eBioscience),
CD206 (eBioscience) and CD11c (eBioscience) were used to stain
M1/M2 macrophages. The stained SVF cells were analyzed
using a FACScan flow cytometer (BD Bioscience) and data
analysis was performed using BD FACSDiva software (BD
Bioscience).
Thiobarbituric acid reactive substance (TBAR) assay
The TBAR assay kit (Cayman Chemicals) was used to measure
lipid peroxidation in the WAT and plasma of mice. WAT (25 mg)
suspended in RIPA buffer was sonicated, centrifuged at 1,600 g
for 10 min at 4uC, and the supernatant was collected. The SDS
solution was added to the supernatant, which was then mixed with
the Color reagent according to the manufacturer’s instructions.
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The sample was boiled for 1 h, centrifuged, and the supernatant
was collected. Fluorescence at the excitation wavelength of
530 nm and emission wavelength of 550 nm was measured.
Macrophage depletion by clodronate
The generation of liposome-encapsulated clodronate was
performed as previously described [38]. Cholesterol (10 mg/ml;
Sigma-Aldrich) was dissolved in 100% ethanol, and 100 mg/ml
phosphatidylcholine in 100% ethanol (Sigma-Aldrich) was made
into a phospho-lipid film by drying with a low-vacuum rotary.
Clodronate (0.6 M) (Sigma-Aldrich) was dissolved in purified
water and incubated with the phospho-lipid film by gentle rotation
at room temperature and sonication in a water bath for 3 min at
55 kHz. After removing the non-encapsulated clodronate, lipo-
some-encapsulated clodronate was resuspended in 1X PBS. Two
intraperitoneal injections (3 days apart) of clodronate were
administered to mice fed a HFD for 8 weeks. IPGTT and ITT
were performed 6 days after the first injection.
Analysis of triglyceride, ceramide, and saturated fatty
acids in tissues
Measurement of hepatic triglycerides: Liver triglycerides were
extracted with chloroform and methanol, dissolved in 16 PBS,
and measured in a Hitachi 7150 chemistry analyzer (Hitachi,
Japan).
Measurement of ceramides in WAT, liver and muscle: Prior to
extraction of total lipids, C17 ceramide was added as an internal
standard. Ceramides were measured as previously described [59].
All liquid chromatography-mass spectrometry (LC-MS/MS)
experiments were performed using an Agilent 1200 HPLC system
(Agilent Technologies, Santa Clara, CA, USA) coupled to a
Thermo LTQ linear ion trap mass spectrometer (Thermo
Scientific, San Jose, CA) equipped with an electro spray ionization
(ESI) source. Briefly, LC separation was achieved using a
LunaC18 RP column (150 mm62 mm I.D., 5 mm 100 A˚
particles; Phenomenex, Torrance, CA) with gradient elution.
Lipid molecules separated by LC were detected by the mass
spectrometer in Positive ESI mode using selected reaction
monitoring (SRM). The SRM channels were arranged as follows:
538R264 for C16, 552R264 for C17, 566R264 for C18,
594R264 for C20, 648R264 for C24:1, and 650R264 for C24.
The peak area was normalized according to the internal standard
and tissue weight. All values are presented as relative differences in
the ratio of the extracted lipids to the internal standard.
To measure the level of saturated fatty acids, tissues were
homogenized in ice-cold methanol, and 1 mg of pentadecanoic
acid (C15:0) was added as an internal standard. Samples were
incubated at 45uC overnight, then cooled to room temperature.
Hexane and 1 mL of H2O were added, samples were vortexed
and centrifuged, and fatty acid methyl esters were collected from
the upper hexane layer. Samples were analyzed by gas chroma-
tography–mass spectrometry (GC-MS) using an Agilent HP6890
GC interfaced with an HP5973N MSD. A DB-5 column was used.
The GC oven temperature was initially 150uC and then increased
to 280uC for 52 min. Full MS scans over a m/z range of 60 to 800
were obtained and the peaks of the characteristic ion chromato-
gram for each fatty acid methyl ester were used for quantification.
All samples were normalized against the internal standard.
Serum analysis
Whole cardiac blood from the mice was incubated at room
temperature for 2 h. The blood was centrifuged at 2,500 rpm for
5 min, and the supernatant was collected. TNFa and IL-4 were
measured using a mouse cytokine/chemokine multiplex panel
(Millipore). MCP1 and IP10 were measured using an ELISA kit
(R&D Systems). Serum triglycerides and FFAs were measured
with a Hitachi 7150 chemistry analyzer (Hitachi, Japan).
Statistical analyses
Data are presented as means 6 or + standard deviation (SD).
Statistical significance for comparisons was determined using the
Student’s two-tailed T-test. A p value less than 0.05 was considered
statistically significant.
Supporting Information
Figure S1 Expression of Crif1 mRNA in the various tissues in
control C57BL/6 mouse, ob/ob and db/db mice. (A) Measurement
of Crif1 mRNA in multiple tissues in 8 weeks-of-aged C57BL/6
male mouse by northern blot analysis. The bars represent the
relative density of Crif1/b-actin mRNA compared with the value of
brain in northern blots. BAT, brown adipose tissue; eWAT,
epididymal white adipose tissue; EDL, extensor digitorum longus;
GA, gastrocnemius. (B) Crif1 expression was measured in 7 weeks
old db/db (left) or ob/ob (right) mice and control heterozygous mice
by real-time PCR, normalized with 18s ribosomal RNA. (n= 6).
Values are means + SD, *p,0.05 versus control mice. (C) Crif1
expression in mice fed a high fat diet (HFD) for 8 weeks starting
from 6 weeks of age (n= 10). Values are means + SD, *p,0.05
versus control mice. NCD, normal chow diet; HFD, high-fat diet.
(PDF)
Figure S2 Impaired non-shivering thermogenesis in Crif1f/f,Fabp4
mice. All analysis of these mice fed with a NCD was performed at
3 weeks-of-age. (A) Hematoxylin and eosin (H&E) staining of
BAT. Scale: 100 mm. (B) Transmission electron microscopy
(TEM) of BAT revealed that the mitochondria of Crif1f/f,Fabp4
mice developed severe swollen cristae (red arrows). L, lipid droplet;
N, nucleus. Scale: 6,000 nm. (C) Number of mitochondria per
area and relative mitochondria size in BAT (n = 20). Values are
means + SD, *p,0.05 versus control mice. (D) Body temperature
was measured rectally with a digital thermometer at an ambient
temperature (23uC) and after emersion in cold water (4uC) for
5 min (n= 5). Values are means + SD. *p,0.05 versus control
mice. (E) Survival rate of Crif1+/+,Fabp4 and Crif1f/f,Fabp4 mice
housed in ambient (23uC) and thermoneutrality (30uC) conditions
(n= 20).
(PDF)
Figure S3 Levels of mitochondrial OXPHOS complexes in non-
adipose tissues of Crif1f/+,Fabp4 mice. (A) Western blotting of Crif1
and the ND1 subunit of OXPHOS complex I in liver and heart.
ND1, subunit of OXPHOS complex I. (B) Blue native-PAGE
analysis of OXPHOS complexes (I, II, III, IV and V) in
mitochondria isolated from liver of Crif1+/+,Fabp4 and Crif1f/+,Fabp4
mice (C) Level of ATP in the heart of Crif1+/+,Fabp4 and
Crif1f/+,Fabp4 mice (n= 8). Values are means + SD. n.s, not
significant.
(PDF)
Figure S4 Adipose development and lipid metabolites in
Crif1f/+,Fabp4 mice. Crif1+/+,Fabp4 and Crif1f/+,Fabp4 mice were
generated from floxed Crif1 mice with Fabp4-Cre recombinase
mice. NCD or a HFD were begun at 6 weeks-of-age. (A) Body
weight changes in mice fed a NCD or 60% HFD for 8 weeks or 14
weeks, starting at 6 weeks-of-age (n= 8). Values are means + SD.
wks, weeks; n.s, not significant. (B) Daily food intake of
Crif1+/+,Fabp4 and Crif1f/+,Fabp4 mice (n= 8). (Crif1+/+,Fabp4,
3.24+0.42 g/day vs Crif1f/+,Fabp4, 2.94+0.14 g/day) Values are
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means + SD. n.s, not significant. (C) MR images in Crif1+/+,Fabp4
and Crif1f/+,Fabp4 mice fed with NCD and HFD for 14 weeks. (D
and E) Serum TG and FFA levels in control (Crif1+/+,Fabp4) and
adipose tissue-specific Crif1 heterozygous mice (Crif1f/+,Fabp4)
(n= 8). Values are means + SD, *p,0.05, n.s, not significant. (F)
TG levels in the liver. The peak area was normalized according to
a liver weight (n= 8). Values are means + SD, *p,0.05 versus
control mice. (G) Combined level of saturated fatty acids such as
C16, C18, C18.1, C18.3, and C20.4 in WAT, gastrocnemius
muscle and liver quantified by gas chromatography–mass
spectrometry (GC-MS). The data was normalized according to
an internal standard and tissue wet weight (n= 4). Values are
means + SD. n.s, not significant. (H) Combined level of ceramides,
such as C16, C18, C20, C22, C24 and C24.1 in the WAT,
gastrocnemius muscle, and liver of mice fed a HFD for 14 weeks
quantified by liquid chromatography-mass spectrometry (LC-MS/
MS). The peak area was normalized according to an internal
standard (C17 ceramide) and tissue weight (n= 4). Values are
means + SD. n.s, not significant.
(PDF)
Figure S5 Gene expression profiles in 3T3-L1 adipocytes
following silencing of Crif1 determined by a complementary
DNA microarray. A microarray was performed using 3T3-L1
adipocytes treated with control or Crif1 siRNA with Agilent’s DNA
microarray Chip. Data were analyzed using the Feature
Extraction and GeneSpring Software (Agilent Technologies).
(PDF)
Figure S6 Activation of p38 MAPK and expression of
chemokines in MEFs. (A) p-p38 MAPK and t-p38 MAPK levels
in control (+/D) and Crif1-null (2/D) MEFs. p38 MAPK, p38
mitogen-activated protein kinases. (B) Real-time PCR with Mcp1
and Ip10 primers in MEF null cells (2/D) (n= 6). Values are
means + SD. n.s, not significant.
(PDF)
Figure S7 ROS and chemokine secretion in mice. (A)
Measurement of lipid peroxidation with the TBAR assay in the
WAT and plasma of Crif1+/+,Fabp4 and Crif1f/+,Fabp4 mice fed a
NCD or HFD for 8 weeks (n= 8). Values are means + SD.
*p,0.05, n.s, not significant. (B) Secreted MCP1 and IP10 levels
in the serum of Crif1+/+,Fabp4 and Crif1f/+,Fabp4 mice fed a NCD or
HFD for 8 weeks (n= 8). Values are means + SD. *p,0.05, n.s,
not significant.
(PDF)
Figure S8 Phenotypic analysis and detection of Cre-recombinase
activity in peritoneal macrophages from Crif1+/+,Fabp4 and
Crif1f/+,Fabp4 mice. (A) Peritoneal macrophages were collected
following intraperitoneal injection of thioglycollate into 6-week-old
Crif1+/+,Fabp4 and Crif1f/+,Fabp4 mice. Expression of Crif1 and
phenotypic markers for M1 and M2 macrophages were measured
by real-time PCR using specific primers (n= 10). Values are means
+ SD. *p,0.05, n.s, not significant. (B) Schematic showing the
loxp site in the Crif1 gene and the location of primers 1, 2, and 3.
(C) PCR analysis of homologous recombination in genomic DNA
extracted from WAT, BAT, and peritoneal macrophages isolated
from 20-week-old control and Crif1f/+,Fabp4 mice. Genomic DNA
for Cre recombinase was detected in WAT, BAT, and peritoneal
macrophages (upper panel), but the recombination product was
only present in WAT and BAT (lower panel).
(PDF)
Figure S9 Generation of adipocyte specific Crif1 knockout
mouse with Adipoq-Cre mice. (A) All analysis of these mice fed
with a NCD was performed at 8 weeks-of-age. Crif1 mRNA levels
in eWAT and BAT of control (Crif1+/+,Adipoq), adipose-specific Crif1
heterozygous (Crif1f/+,Adipoq), and homozygous (Crif1f/f,Adipoq) knock-
out mice (n= 6). Values are means + SD. *p,0.05 versus the
control mice. (B) Western blot analysis of Crif1, subunit of
OXPHOX complex I (ND1 and NDUFA9), OXPHOX complex
III (UQCRC2), OXPHOX complex IV (COX4) in eWAT, BAT,
heart and liver from the three strains of mice. (C) The body
temperature of 3-week-old mice was measured when exposed to
an ambient temperature (23uC) and after emersion in cold water
(4uC) for 5 min (n = 5). Values are means + SD. *p,0.05 versus
control mice, n.s, not significant.
(PDF)
Figure S10 Metabolic phenotypes of liver specific- or skeletal
muscle specific-Crif1 KO mice. (A and B) Body weight and daily
food intake of control (Crif1+/+,Alb) and liver specific-Crif1
homozygous KO mice (Crif1f/f,Alb) fed a HFD diet for 8 weeks
(n= 8). Values are means + SD. n.s, not significant. (C) IPGTT
experiment with Crif1+/+,Alb and Crif1f/f,Alb mice injected with 1 g/
kg glucose after 16 h of fasting (n= 8). Values are means6 SD. (D)
Real time PCR with specific primers to measure gluconeogenic
gene expression in the livers of fasted mice. (E) Body weight of
control (Crif1+/+,MLC) and skeletal muscle-specific Crif1 haploin-
sufficientt mice (Crif1f/+,MLC) fed a NCD diet. Values are means +
SD. n.s, not significant. (F) IPGTT experiment with Crif1f/+,MLC
mice injected with 2 g/kg glucose after 16 h of fasting (n= 8).
Values are means 6 SD.
(PDF)
Table S1 Summary of the phenotypes of adipocyte-specific Crif1
mutant mice under the control of the Fabp4-Cre or Adipoq-Cre
promoters. The percentages represent residual levels in compar-
ison to control mice.* The band intensities of Crif1 protein were
determined by Western blot analysis using 6 male mice per group.
** Adipose mass was evaluated by totaling the weights of eWAT of
6 male mice per group. n.d; not determined.
(DOCX)
Table S2 Sequence of primers used in real-time PCR.
(DOCX)
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